Balaji Balagani: Exploring Stable vs Unstable vs Complete Coronary Block
Balaji Balagani, Cardiologist in Guntur, GKNM Hospital, shared a post on X:
“Stable vs Unstable vs Complete Coronary Block
What’s the difference?
1. Stable Blockage
A stable plaque usually has a thick fibrous covering and causes a fixed narrowing of the coronary artery.
- Blood flow is reduced mainly during exertion.
- Chest pain is usually predictable and occurs with activity.
- Symptoms often improve with rest.
- This is typically associated with Chronic Coronary Syndrome / Stable Angina.
2. Unstable Blockage
An unstable or vulnerable plaque can rupture or erode suddenly, even if the blockage was not very severe.
- A blood clot (thrombus) can form suddenly.
- Blood flow may decrease abruptly.
- Chest pain can occur at rest, become more frequent, or worsen suddenly.
- This can lead to Acute Coronary Syndrome (ACS) — unstable angina or NSTEMI.
3. Complete Coronary Occlusion
When a coronary artery becomes completely blocked, usually due to an acute thrombus over a ruptured plaque, blood flow can be severely interrupted.
- Can cause a major myocardial infarction (heart attack).
- Acute complete occlusion is commonly associated with STEMI, although ECG presentation can vary.
- Urgent reperfusion treatment may be lifesaving.
Important:
A 90% blockage is not always more dangerous than a 50% blockage.
A seemingly mild plaque can suddenly rupture and cause a large blood clot, resulting in a heart attack.
The danger is not determined only by the percentage of blockage — plaque stability and sudden thrombosis matter greatly.
Know your heart.
Recognize the warning signs.
Seek medical attention early.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial